New HIV vaccine and antibody cocktail aims to free patients from daily meds
Disease control
Completed
This study tested a two-part vaccine (Ad26.Mos4.HIV and MVA-BN-HIV) combined with three broadly neutralizing antibodies (PGT121, PGDM1400, VRC07-523LS) in 28 adults with HIV who were already on suppressive antiretroviral therapy (ART). The goal was to see if this combination coul…
Phase: PHASE1, PHASE2 • Sponsor: Boris Juelg, MD PhD • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC